financetom
Business
financetom
/
Business
/
Bill Holdings Stock Plunges On Q2 Earnings: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bill Holdings Stock Plunges On Q2 Earnings: What's Going On?
Feb 6, 2025 2:33 PM

BILL Holdings Inc ( BILL ) shares are diving in Thursday’s after-hours session after the company reported second-quarter financial results. Here’s a rundown of the report.

Q2 Revenue: $362.55 million, versus estimates of $360.23 million

Q2 Adjusted EPS: 56 cents, versus estimates of 46 cents

Total revenue increased 14% year-over-year, while core revenue climbed 16%. Core revenue consists of subscription and transaction fees. The company ended the quarter with $1.57 billion in cash and cash equivalents.

“We delivered strong financial results and innovated at a rapid pace as we executed on our vision to be the de facto intelligent financial operations platform for SMBs,” said René Lacerte, founder and CEO of Bill Holdings ( BILL ).

“We are leveraging our leadership position to empower small and mid-sized businesses and the partners that we serve, and we are extending our lead by expanding the depth and breadth of our platform and diverse distribution ecosystem. Today, more than 480,000 businesses rely on BILL to manage their day-to-day financial workflow. We are moving fast to address a vast market opportunity to transform the financial operations for millions of SMBs.”

See Also: Amazon.com Q4 Earnings: Jassy Highlights ‘Successful’ Holiday Season, Q1 Guidance Disappoints Investors

What’s Next: Bill Holdings ( BILL ) expects third-quarter revenue of $352.5 million to $357.5 million versus estimates of $360.36 million. The company sees third-quarter adjusted earnings in the range of 35 cents to 38 cents per share versus estimates of 34 cents per share, according to Benzinga Pro.

Bill Holdings ( BILL ) also raised its full-year outlook. The company expects full-year revenue of $1.45 billion to $1.47 billion versus estimates of $1.46 billion. Bill expects full-year adjusted earnings to be between $1.87 and $1.97 per share.

Management is currently discussing the quarter on a conference call that started at 4:30 p.m. ET.

BILL Price Action: Bill Holdings ( BILL ) shares were down 31.76% after hours, trading at $65.75 at the time of publication Thursday, according to Benzinga Pro.

This illustration was generated using artificial intelligence via Midjourney.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved